Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 2/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 2/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23473642 | 0.83 | TNKS (0.39) | TNKSTNKS2MAPTALOX5PIM1 | |
| SCHEMBL19169626 | 0.81 | TNKS (0.40) | TNKSTNKS2MAPTMEN1HTT | |
| SCHEMBL19106204 | 0.80 | MEN1 (0.37) | TNKSTNKS2MAPTMEN1KMT2A | |
| SCHEMBL23874643 | 0.80 | TNKS (0.35) | TNKSTNKS2MAPTMEN1HTT | |
| SCHEMBL24127783 | 0.80 | TNKS (0.32) | TNKSTNKS2MEN1KMT2AALOX5 | |
| SCHEMBL24127779 | 0.80 | TNKS (0.32) | TNKSTNKS2MEN1KMT2AALOX5 | |
| SCHEMBL18859537 | 0.80 | TNKS (0.36) | TNKSTNKS2MAPTALOX5PIM1 | |
| SCHEMBL19997891 | 0.79 | MEN1 (0.36) | TNKSTNKS2MEN1KMT2AALOX5 | |
| SCHEMBL24127781 | 0.79 | PIM1 (0.33) | TNKSTNKS2MEN1KMT2APIM1 | |
| SCHEMBL18666501 | 0.79 | TNKS (0.35) | TNKSTNKS2MAPTMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220045281-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2022-02-10 | — | — | US | disclosed |
| US-20210320263-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220045281-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ELAVL1, ICOSLG, OR10J3 | TNKS 3335/4885TNKS2 3029/4885MAPT 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.